CLONOMAB • Genel araştırmalar,PARIS
Yöneticiler CLONOMAB Yönetici listesini indir
Location - CLONOMAB
Önemli Bilgiler CLONOMAB
Faaliyetler CLONOMAB
Diğer sınıflandırmalar (yalnızca bazı ülkeler için)
NAF Rev.2 (FR 2008) : Research and experimental development on biotechnology (7211Z)
NACE Rev.2 (EU 2008) : Research and experimental development on biotechnology (7211)
ISIC 4 (WORLD) : Research and experimental development on natural sciences and engineering (7210)
NACE Rev.2.1 (EU 2025) : Research and experimental development on natural sciences and engineering (7210)
Kompass membership
| Kompass ID? | FRA00DRIX |
|---|
Legal information - CLONOMAB
| Type | Bir seçenek olarak mevcut bilgi |
|---|---|
| Kuruluş yılı | Bir seçenek olarak mevcut bilgi|
| Hukuki yapı | Bir seçenek olarak mevcut bilgi |
| Faaliyetler (NAF08) | Research and experimental development on biotechnology (7211Z) |
| Şirket sermayesi | Bir seçenek olarak mevcut bilgi|
| SIREN | Bir seçenek olarak mevcut bilgi |
| SIRET (Siège) | Bir seçenek olarak mevcut bilgi |
| Vergi numarası |
Bir seçenek olarak mevcut bilgi
|
| No employees (address) | Bir seçenek olarak mevcut bilgi |
| Çalışan yok | Bir seçenek olarak mevcut bilgi |
Other Companies recommended by Kompass:
Bunları da beğenebilirsiniz:
Need help finding the right information ? Let us guide you to the best solutions !
I am looking for :
The shortest path to your future customers and suppliers
"I would recommend EasyBusiness to all sales teams."
Test EasyBusiness for 14 days for free
No payment or credit card required
All-in-one prospecting solution designed to improve your productivity
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR).
You may object to its processing by email: dpo@kompass.com.
Find out more: see our privacy policy.